Compounds > medica 16
Page last updated: 2024-09-03

medica 16 and Neoplasms

medica 16 has been researched along with Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abramson, HN1
Granchi, C1

Reviews

1 review(s) available for medica 16 and Neoplasms

ArticleYear
ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.
    European journal of medicinal chemistry, 2018, Sep-05, Volume: 157

    Topics: Antineoplastic Agents; ATP Citrate (pro-S)-Lyase; Dose-Response Relationship, Drug; Glucose; Humans; Lipid Metabolism; Molecular Structure; Neoplasms; Structure-Activity Relationship

2018

Other Studies

1 other study(ies) available for medica 16 and Neoplasms

ArticleYear
The lipogenesis pathway as a cancer target.
    Journal of medicinal chemistry, 2011, Aug-25, Volume: 54, Issue:16

    Topics: Acetyl-CoA Carboxylase; Animals; Antineoplastic Agents; ATP Citrate (pro-S)-Lyase; Biosynthetic Pathways; Fatty Acid Synthases; Fatty Acids; Humans; Lipogenesis; Models, Chemical; Molecular Structure; Neoplasms

2011